FDA

ZoomMax and ZapMax capsules recalled due to undeclared drugs

November 7, 2024

Boulla LLC is voluntarily recalling lot YZM240406 of ZoomMax and ZapMax Capsules due to contamination with sildenafil and diclofenac, which are not approved for use in dietary supplements. These products, marketed for male performance and energy, were sold on Amazon.

The recall follows FDA testing that revealed the presence of the undeclared drugs. Sildenafil, used for erectile dysfunction, and diclofenac, an NSAID, pose significant health risks, including severe blood pressure drops and increased cardiovascular events, respectively. Sildenafil can dangerously interact with nitrates, commonly prescribed for heart conditions, while diclofenac can cause serious gastrointestinal and cardiovascular issues.

No adverse events have been reported to date.

Source:

(2024, November 4). FDA. Boulla LLC Issues Voluntary Nationwide Recall of ZoomMax and ZapMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/boulla-llc-issues-voluntary-nationwide-recall-zoommax-and-zapmax-capsules-due-presence-undeclared